Grossesse et vaccination contre le Covid-19 : risque-bénéfice

Jacquerioz, Frédérique Aline

doi:10.53738/REVMED.2022.18.807.2350

Scientific article

Comment

French

Grossesse et vaccination contre le Covid-19 : risque-bénéfice

ContributorsJacquerioz, Frédérique Aline

Published inRevue médicale suisse, vol. 18, no. 807

Publication date2022-12-07

Abstract

Rubrique "lu pour vous".

Concerne: Sadarangani M, et al. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet Infect Dis. 2022 Nov;22(11):1553-64. DOI: 10.1016/S1473-3099(22)00426-1.

Keywords

Female
Pregnancy
Humans
COVID-19
Vaccination
Risk Assessment

Affiliation

Citation (ISO format)

JACQUERIOZ, Frédérique Aline. Grossesse et vaccination contre le Covid-19 : risque-bénéfice. In: Revue médicale suisse, 2022, vol. 18, n° 807. doi: 10.53738/REVMED.2022.18.807.2350

Article (Published version)

06/08/2024

Identifiers

PID : unige:169978
DOI : 10.53738/REVMED.2022.18.807.2350
PMID : 36477284

Commercial URLhttps://www.revmed.ch/revue-medicale-suisse/2022/revue-medicale-suisse-807/grossesse-et-vaccination-contre-le-covid-19-risque-benefice

ISSN of the journal1660-9379

10views

1downloads

Creation03/27/2023 1:25:13 PM

First validation07/05/2023 4:48:43 PM

Update time07/05/2023 4:48:43 PM

Status update07/05/2023 4:48:43 PM

Last indexation08/31/2023 11:55:31 AM

Archive ouverte UNIGE

Grossesse et vaccination contre le Covid-19 : risque-bénéfice

Rubrique "lu pour vous". Concerne: Sadarangani M, et al. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet Infect Dis. 2022 Nov;22(11):1553-64. DOI: 10.1016/S1473-3099(22)00426-1.

Technical informations

Rubrique "lu pour vous".

Concerne: Sadarangani M, et al. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet Infect Dis. 2022 Nov;22(11):1553-64. DOI: 10.1016/S1473-3099(22)00426-1.